We provide you with 20 years of free, institutional-grade data for CPRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CPRX. Explore the full financial landscape of CPRX stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1369568 | CPRX | 10-Q | Url |
| 2025-05-07 | 1369568 | CPRX | 10-Q | Url |
| 2025-02-26 | 1369568 | CPRX | 10-K | Url |
| 2024-11-06 | 1369568 | CPRX | 10-Q | Url |
| 2024-08-07 | 1369568 | CPRX | 10-Q | Url |
| 2024-05-08 | 1369568 | CPRX | 10-Q | Url |
| 2024-02-28 | 1369568 | CPRX | 10-K | Url |
| 2023-11-08 | 1369568 | CPRX | 10-Q | Url |
| 2023-08-09 | 1369568 | CPRX | 10-Q | Url |
| 2023-05-10 | 1369568 | CPRX | 10-Q | Url |
| 2023-03-15 | 1369568 | CPRX | 10-K | Url |
| 2022-11-09 | 1369568 | CPRX | 10-Q | Url |
| 2022-08-09 | 1369568 | CPRX | 10-Q | Url |
| 2022-05-10 | 1369568 | CPRX | 10-Q | Url |
| 2022-03-16 | 1369568 | CPRX | 10-K | Url |
| 2021-11-09 | 1369568 | CPRX | 10-Q | Url |
| 2021-08-09 | 1369568 | CPRX | 10-Q | Url |
| 2021-05-10 | 1369568 | CPRX | 10-Q | Url |
| 2021-03-15 | 1369568 | CPRX | 10-K | Url |
| 2020-11-09 | 1369568 | CPRX | 10-Q | Url |
| 2020-08-10 | 1369568 | CPRX | 10-Q | Url |
| 2020-05-11 | 1369568 | CPRX | 10-Q | Url |
| 2020-03-16 | 1369568 | CPRX | 10-K | Url |
| 2019-11-12 | 1369568 | CPRX | 10-Q | Url |
| 2019-08-07 | 1369568 | CPRX | 10-Q | Url |
| 2019-05-10 | 1369568 | CPRX | 10-Q | Url |
| 2019-03-18 | 1369568 | CPRX | 10-K | Url |
| 2018-11-07 | 1369568 | CPRX | 10-Q | Url |
| 2018-08-07 | 1369568 | CPRX | 10-Q | Url |
| 2018-05-09 | 1369568 | CPRX | 10-Q | Url |
| 2018-03-14 | 1369568 | CPRX | 10-K | Url |
| 2017-11-08 | 1369568 | CPRX | 10-Q | Url |
| 2017-08-09 | 1369568 | CPRX | 10-Q | Url |
| 2017-05-10 | 1369568 | CPRX | 10-Q | Url |
| 2017-03-15 | 1369568 | CPRX | 10-K | Url |
| 2016-11-09 | 1369568 | CPRX | 10-Q | Url |
| 2016-08-09 | 1369568 | CPRX | 10-Q | Url |
| 2016-05-10 | 1369568 | CPRX | 10-Q | Url |
| 2016-03-15 | 1369568 | CPRX | 10-K | Url |
| 2015-11-09 | 1369568 | CPRX | 10-Q | Url |
| 2015-08-10 | 1369568 | CPRX | 10-Q | Url |
| 2015-05-11 | 1369568 | CPRX | 10-Q | Url |
| 2015-03-13 | 1369568 | CPRX | 10-K | Url |
| 2014-11-13 | 1369568 | CPRX | 10-Q | Url |
| 2014-08-13 | 1369568 | CPRX | 10-Q | Url |
| 2014-05-15 | 1369568 | CPRX | 10-Q | Url |
| 2014-03-19 | 1369568 | CPRX | 10-K | Url |
| 2013-11-13 | 1369568 | CPRX | 10-Q | Url |
| 2013-08-14 | 1369568 | CPRX | 10-Q | Url |
| 2013-05-15 | 1369568 | CPRX | 10-Q | Url |
| 2013-04-01 | 1369568 | CPRX | 10-K | Url |
| 2012-11-14 | 1369568 | CPRX | 10-Q | Url |
| 2012-08-14 | 1369568 | CPRX | 10-Q | Url |
| 2012-05-15 | 1369568 | CPRX | 10-Q | Url |
| 2012-04-06 | 1369568 | CPRX | S-1 | Url |
| 2012-03-30 | 1369568 | CPRX | 10-K | Url |
| 2011-11-14 | 1369568 | CPRX | 10-Q | Url |
| 2011-08-15 | 1369568 | CPRX | 10-Q | Url |
| 2011-05-13 | 1369568 | CPRX | 10-Q | Url |
| 2011-03-31 | 1369568 | CPRX | 10-K | Url |
| 2010-11-15 | 1369568 | CPRX | 10-Q | Url |
| 2010-08-12 | 1369568 | CPRX | 10-Q | Url |
| 2010-05-17 | 1369568 | CPRX | 10-Q | Url |
| 2010-03-31 | 1369568 | CPRX | 10-K | Url |
| 2009-11-12 | 1369568 | CPRX | 10-Q | Url |
| 2009-08-06 | 1369568 | CPRX | 10-Q | Url |
| 2009-05-13 | 1369568 | CPRX | 10-Q | Url |
| 2009-03-26 | 1369568 | CPRX | 10-K | Url |
| 2008-11-13 | 1369568 | CPRX | 10-Q | Url |
| 2008-08-14 | 1369568 | CPRX | 10-Q | Url |
| 2008-05-15 | 1369568 | CPRX | 10-Q | Url |
| 2008-03-25 | 1369568 | CPRX | 10-K | Url |
| 2007-11-14 | 1369568 | CPRX | 10-Q | Url |
| 2007-08-10 | 1369568 | CPRX | 10-Q | Url |
| 2007-05-14 | 1369568 | CPRX | 10-Q | Url |
| 2007-04-02 | 1369568 | CPRX | 10-K | Url |
| 2006-12-15 | 1369568 | CPRX | 10-Q | Url |
| 2006-07-25 | 1369568 | CPRX | S-1 | Url |
Catalyst Pharmaceuticals, Inc(NASDAQ:CPRX) 
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphat...
Website: http://www.catalystpharma.com
Founded: 2002
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CPRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.